Pevonedistat sensitizes cancer cells to oncolytic VSVd51 virotherapy
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
To investigate the ability for pevonedistat to sensitize renal 786-0 carcinoma cells to VSVd51 oncolyic virotherapy, we treated cells with monotherapies or combination and sequencinced the transcriptome for antiviral interferon impact Overall design: RNA was extracted after 24 hours of infection with VSVd51 from each condition and subject to sequencing.
创建时间：
2023-12-29
